MedTrace Logo

Valdecoxib in Treating Chronic Pain in Cancer Patients

NCT00021996 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2013-07-18

No results posted yet for this study

Summary

RATIONALE: Valdecoxib may be effective in relieving chronic pain in cancer patients. It is not yet known if valdecoxib is effective in treating chronic pain.

PURPOSE: Randomized clinical trial to study the effectiveness of valdecoxib in relieving chronic pain in cancer patients.

Conditions

  • Pain
  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

valdecoxib

Sponsors & Collaborators

Principal Investigators

  • Susana Campos, MD, MPH · Dana-Farber Cancer Institute

Study Design

Purpose
SUPPORTIVE_CARE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-31
Completion
2004-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00021996 on ClinicalTrials.gov